Daphne Karydas

Insider Reports History

Location
Waltham, MA
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daphne Karydas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director Common Stock 0 $0 $46.36 13 Nov 2025 Direct
COMPASS Pathways plc Director Share Option (Right to Buy) 26,000 12 Jun 2025 Direct
Mineralys Therapeutics, Inc. Director Stock Option 17,900 13 Nov 2025 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 16 Nov 2022 Direct

Insider Reports Filed by Daphne Karydas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MLYS Mineralys Therapeutics, Inc. 13 Nov 2025 4 -$536,797 4 Director 13 Nov 2025, 19:01
CMPS COMPASS Pathways plc 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 08:18
MLYS Mineralys Therapeutics, Inc. 13 Feb 2025 1 $0 4 Director 24 Feb 2025, 18:58
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director 23 May 2024, 16:21
CMPS COMPASS Pathways plc 09 May 2024 1 $0 4 Director 13 May 2024, 06:44
CMPS COMPASS Pathways plc 18 Sep 2023 1 $0 4 Director 20 Sep 2023, 18:58
CMPS COMPASS Pathways plc 18 Sep 2023 0 $0 3 Director 20 Sep 2023, 18:54
MLYS Mineralys Therapeutics, Inc. 13 Sep 2023 0 $0 3 Director 14 Sep 2023, 16:14
MLYS Mineralys Therapeutics, Inc. 13 Sep 2023 1 $0 4 Director 14 Sep 2023, 16:13
/report/000089924322036295-karydas-daphne-2022-11-16 LogicBio Therapeutics, Inc. 16 Nov 2022 1 $0 4 Director 17 Nov 2022, 20:07
/report/000120919122040376-karydas-daphne-2022-06-17 LogicBio Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 05 Jul 2022, 06:59
/report/000120919121040427-karydas-daphne-2021-06-11 LogicBio Therapeutics, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:00